Summit Therapeutics Inc.
AstraZeneca partners with Summit for cancer research.
1 source·02/10, 14:36·yahoo.com
Collaboration with AstraZeneca boosts future growth potential.
1 source·02/10, 07:00·finviz.com
New collaboration for drug evaluation with key partners.
AstraZeneca deepens Summit ties on ADC-bispecific cancer combo testing pact
finviz·yahoo.com·02/10, 14:31
Summit Teams Up With Daiichi Sankyo, AstraZeneca For Cancer Therapy Trial CEO Calls It An Important Expansion
finviz·yahoo.com·02/10, 12:39
Summit Therapeutics Announces Clinical Trial Collaboration with AstraZeneca and Daiichi Sankyo to Evaluate Ivonescimab in Combination with TROP2-Directed ADC Datroway
·
Positive trial results for ivonescimab reported.
1 source·07/11, 14:28·sec.gov
Summit Therapeutics raises $500 million in private placement.
1 source·22/10, 12:58·sec.gov
Positive clinical trial results and expansion of ivonescimab.
1 source·20/10, 18:03·sec.gov
10-Q form submitted!
1 source·20/10, 17:58·sec.gov
Positive Phase III trial data presented at major conference.
1 source·08/09, 11:46·sec.gov
Financial results and operational progress announced.
1 source·11/08, 21:14·sec.gov
Amendment increases stock offering potential by $360 million.
1 source·11/08, 20:52·sec.gov
Daiichi Sankyo and AstraZeneca Enter into Clinical Trial Collaboration with Summit Therapeutics to Evaluate Datroway in Combination with Ivonescimab Across Multiple Tumor Types
finviz·finviz.com·02/10, 06:30
SMMT Stock Soars After-Hours: Did AstraZeneca Just End Summits Cash Scare?
finviz·yahoo.com·28/09, 23:43
Summit Therapeutics Stock Surges After AstraZeneca Reveals $2 Billion Investment
finviz·barrons.com·28/09, 22:43
Summit shares surge after-hours on $2 billion AstraZeneca equity deal
finviz·yahoo.com·28/09, 22:43